Latest news
Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026 - StocktwitsStocktwits · Fri, 07 Aug 2026 20:17:05 GMTMerck is pharma’s most patent-exposed company. Now it’s reinventing itself. - Pharma VoicePharma Voice · Wed, 05 Aug 2026 13:30:22 GMTMerck hikes revenue outlook as new drug sales grow, but cuts profit guidance due to deal charges - CNBCCNBC · Tue, 04 Aug 2026 10:34:21 GMTMerck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in a rare lung disease - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 10:30:00 GMT